Engineering Core-Shell Structures of Magnetic Ferrite Nanoparticles for High Hyperthermia Performance.

Area of Science:

• Materials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Magnetic ferrite nanoparticles (MFNs) are crucial for hyperthermia cancer therapy due to their heating capabilities.
• Conventional MFNs often exhibit low specific loss power (SLP), limiting their therapeutic efficacy.
• Enhancing SLP is essential for improving MFN performance in hyperthermia applications.

Purpose of the Study:

• To increase the specific loss power (SLP) of magnetic ferrite nanoparticles (MFNs) by engineering core-shell structures.
• To investigate the impact of composition and dimensions on the hyperthermia performance of MFNs.
• To compare the efficacy of novel core-shell MFNs against commercial nanoparticles.

Main Methods:

• Synthesis of core ferrite nanoparticles: magnetite (mag), cobalt ferrite (cf), and zinc cobalt ferrite (zcf).
• Fabrication of eight bi-magnetic core-shell MFNs using a modified controlled co-precipitation method.
• Evaluation of SLP values under varying magnetic field strengths and frequencies, adhering to safety limits.

Main Results:

• The mag@zcf1 core-shell MFN exhibited the highest SLP (379.2 W/gmetal) at 50 kA/m and 97 kHz.
• The cf@mag1 core-shell MFN showed the lowest SLP (1.7 W/gmetal) at 40 kA/m and 97 kHz.
• Magnetic properties and shell thickness significantly influence heating efficiency and hyperthermia performance.

Conclusions:

• Engineered core-shell structures significantly enhance the specific loss power (SLP) of magnetic ferrite nanoparticles.
• The mag@zcf1 composition demonstrates superior heating efficiency, making it a promising candidate for hyperthermia.
• Tailoring MFN composition and dimensions is a viable strategy for optimizing hyperthermia treatment efficacy.